Annual report pursuant to Section 13 and 15(d)

Note 22 - Segment Information: Schedule of Segment Information (Tables)

v3.20.1
Note 22 - Segment Information: Schedule of Segment Information (Tables)
12 Months Ended
Dec. 31, 2019
Tables/Schedules  
Schedule of Segment Information

 

 

 

Cannabis and Medical Marijuana Segment

 

Facilities Operations Related

 

Corporate and Eliminations

 

Consolidated

2019

 

 

 

 

 

 

 

 

Net sales

$

158,614

$

4,167,858

$

-

$

4,326,472

Operating income (loss)

 

(796,232)

 

74,128

 

(1,023,839)

 

(1,745,943)

Interest income

 

23,561

 

10

 

84,542

 

108,113

Interest expense

 

-

 

26,921

 

(4,325)

 

22,596

Total assets

 

1,572,998

 

1,646,867

 

1,746,712

 

4,966,577

Property additions

 

-

 

11,766

 

-

 

13,484

Depreciation and amortization

 

-

 

11,333

 

11,780

 

23,113

 

 

 

 

 

 

 

 

 

2018

 

 

 

 

 

 

 

 

Net sales

$

1,647,735

$

3,633,798

$

-

$

5,281,533

Operating income (loss)

 

431,971

 

17,395

 

(1,036,796)

 

(587,430)

Interest income

 

83,398

 

4

 

84,803

 

168,205

Interest expense

 

377

 

19,658

 

(2,628)

 

17,407

Total assets

 

4,571,778

 

1,228,783

 

2,292,102

 

8,092,663

Property additions

 

-

 

13,484

 

12,256

 

25,740

Depreciation and amortization

 

-

 

12,493

 

8,269

 

20,762